Novo Nordisk A/S (NVO) to Inject Up to $3.7 Billion on Diabetes Pills
10/7/2013 8:50:38 AM
Novo Nordisk plans to invest up to 20 billion Danish crowns ($3.65 billion) on developing diabetes tablets intended to replace traditional insulin injections, it said on Monday. The Danish company said it planned to spend the money through to 2020 on six diabetes pills it has under development and that the sum included potential production facilities. It estimates the global market for diabetes tablets could be worth more than 100 billion crowns a year from the beginning of the next decade, a spokesperson said, confirming a report in the Danish business newspaper Borsen.
Help employers find you! Check out all the jobs and post your resume.
comments powered by